High rates of comorbidity are found in childhood-onset schizophrenia.

Abstract:

BACKGROUND:For adults with schizophrenia, comorbidity is common and contributes to impairment. Thus, there has been an increasing effort to identify and treat comorbid symptoms. This report extends that work by examining comorbidity in children and young adolescents with childhood-onset schizophrenia. METHODS:Eighty-two children, ages 4-15 years, with schizophrenia or schizoaffective disorder received structured diagnostic instruments for symptoms and pharmacological treatment history. DSM-IV diagnoses were identified using a non-hierarchical approach. RESULTS:Eighty-one (99%) of the children with schizophrenia or schizoaffective disorder had at least one comorbid psychiatric illness: attention deficit hyperactivity disorder (84%), oppositional defiant disorder (43%), depression (30%), and separation anxiety disorder (25%) were the most common comorbid conditions identified. Pharmacological treatment of the comorbid conditions was uncommon. DISCUSSION:Comorbid syndromes are common in children and young adolescents with schizophrenia or schizoaffective disorder. Pharmacological treatment of the comorbid conditions is rare; however it is unclear if this is due to DSM-IVs hierarchical diagnostic system or to a lack of empirically driven guidelines for appropriate treatment. Additional efforts focused on comorbidity in very-early-onset schizophrenia are warranted.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Ross RG,Heinlein S,Tregellas H

doi

10.1016/j.schres.2006.07.006

subject

Has Abstract

pub_date

2006-12-01 00:00:00

pages

90-5

issue

1-3

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(06)00321-5

journal_volume

88

pub_type

杂志文章
  • Effects of mental illness and aging in two thalamic nuclei.

    abstract::We previously reported a schizophrenia associated reduction of neuronal and oligodendrocyte number in the anterior principal thalamic nucleus (APN) in a cohort of severely impaired elderly subjects with schizophrenia (SZ) relative to age matched nonpsychiatric controls (NCs). The present study was undertaken to determ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.08.023

    authors: Byne W,Tatusov A,Yiannoulos G,Vong GS,Marcus S

    更新日期:2008-12-01 00:00:00

  • Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia.

    abstract:BACKGROUND:Verbal and visual memory deficits are prominent trait markers for schizophrenia, with impairments also observed in first-degree relatives [Snitz, B.E., Macdonald, A.W., 3rd, & Carter, C.S. (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of put...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.05.027

    authors: Skelley SL,Goldberg TE,Egan MF,Weinberger DR,Gold JM

    更新日期:2008-10-01 00:00:00

  • Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.

    abstract:BACKGROUND:Cognitive impairment is a core feature of schizophrenia. Some evidence suggests an association between cognition deficits and gray matter reductions. In this study, we investigated the relationship between cognitive performance and gray matter volumes in patients with treatment-naïve, first-episode schizophr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.12.015

    authors: Guo X,Li J,Wang J,Fan X,Hu M,Shen Y,Chen H,Zhao J

    更新日期:2014-02-01 00:00:00

  • Cognitive predictors of symptom change for participants in vocational rehabilitation.

    abstract:BACKGROUND:This study explored the relationship between cognitive impairments and their impact on rate of symptom improvement in a 26 week work therapy program. METHOD:Data were abstracted from the archives of 157 outpatients with SCID confirmed DSM-IV diagnoses of schizophrenia or schizoaffective disorder who partici...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.08.010

    authors: Bell MD,Tsang HW,Greig T,Bryson G

    更新日期:2007-11-01 00:00:00

  • Impaired theta-gamma coupling during working memory performance in schizophrenia.

    abstract:BACKGROUND:Working memory deficits represent a core feature of schizophrenia. These deficits have been associated with dysfunctional dorsolateral prefrontal cortex (DLPFC) cortical oscillations. Theta-gamma coupling describes the modulation of gamma oscillations by theta phasic activity that has been directly associate...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.01.044

    authors: Barr MS,Rajji TK,Zomorrodi R,Radhu N,George TP,Blumberger DM,Daskalakis ZJ

    更新日期:2017-11-01 00:00:00

  • Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients.

    abstract::Schizophrenia is associated with premature mortality and a high rate of sudden, unexpected deaths. Autopsy data are scant, and in studies using death certificates or root cause assessments, a majority of sudden deaths remained unexplained. In the community, post-mortem data indicate that the most common cause of sudde...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.03.011

    authors: Ifteni P,Correll CU,Burtea V,Kane JM,Manu P

    更新日期:2014-05-01 00:00:00

  • EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis.

    abstract:INTRODUCTION:EEG power in the delta, theta and beta1 bands has been shown to be positively correlated with negative symptoms in first episode psychotic patients. The present study investigates this correlation in an "at risk mental state for psychosis" (ARMS) with the aim to improve prediction of transition to psychosi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.08.031

    authors: Zimmermann R,Gschwandtner U,Wilhelm FH,Pflueger MO,Riecher-Rössler A,Fuhr P

    更新日期:2010-11-01 00:00:00

  • Exposure to "The Troubles" in Northern Ireland influences the clinical presentation of schizophrenia.

    abstract:INTRODUCTION:This study investigates the effect of exposure to "The Troubles" (the period of civil unrest from 1968 onwards) in Northern Ireland on symptomatology in people with schizophrenia. METHOD:Eighty-two participants were assessed on a number of psychiatric rating scales and on measures of trauma, including an ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.02.012

    authors: Mulholland C,Boyle C,Shannon C,Huda U,Clarke L,Meenagh C,Dempster M

    更新日期:2008-07-01 00:00:00

  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.

    abstract:BACKGROUND:Evidence indicating that symptoms of non-clinical psychosis (NCP) occur in 6-8% of the general population suggests that psychosis may occur across a continuum. Although a number of studies have examined environmental contributors, to date there have been few investigations of biological/genetic factors in th...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.06.018

    authors: Mittal VA,Smolen A,Dean DJ,Pelletier AL,Lunsford-Avery J,Smith A

    更新日期:2012-09-01 00:00:00

  • A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia.

    abstract::The objective of this study was to evaluate the efficacy, safety and tolerability of brexpiprazole versus placebo in adults with acute schizophrenia. This was a 6-week, multicenter, placebo-controlled double-blind phase 3 study. Patients with acute schizophrenia were randomized to brexpiprazole 1, 2 or 4 mg, or placeb...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.schres.2015.01.038

    authors: Kane JM,Skuban A,Ouyang J,Hobart M,Pfister S,McQuade RD,Nyilas M,Carson WH,Sanchez R,Eriksson H

    更新日期:2015-05-01 00:00:00

  • Disrupted salience processing involved in motivational deficits for real-life activities in patients with schizophrenia.

    abstract::Motivational deficits in patients with schizophrenia adversely affect various domains of daily living. This symptom in everyday life situations manifests in a complex behavioral pattern whose root cannot be simplified to an impaired reward-motivation scheme. This study aimed to identify impairment of the salience netw...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.01.019

    authors: Kim BH,Shin YB,Kyeong S,Lee SK,Kim JJ

    更新日期:2018-07-01 00:00:00

  • Is poor premorbid functioning a risk factor for suicide attempts in first-admission psychosis?

    abstract:BACKGROUND:While poor premorbid functioning is associated with poorer outcomes in psychotic illnesses, little is known about whether it is also a risk factor for suicide attempts. OBJECTIVE:The current study examined the association of premorbid functioning and suicide attempts in a county-wide cohort of first-admissi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.11.005

    authors: Bakst S,Rabinowitz J,Bromet EJ

    更新日期:2010-02-01 00:00:00

  • Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents?

    abstract::Recent research on risk for psychosis has focused on youth who manifest subclinical signs that are often associated with the prodrome to psychosis. Standardized measures of prodromal symptoms have been shown to significantly enhance prediction of risk for conversion to an Axis I psychotic disorder. In the present stud...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.03.034

    authors: Simeonova DI,Attalla A,Trotman H,Esterberg M,Walker EF

    更新日期:2011-08-01 00:00:00

  • Building models for postmortem abnormalities in hippocampus of schizophrenics.

    abstract::Postmortem studies have suggested that there is abnormal GABAergic activity in the hippocampus in schizophrenia (SZ). In micro-dissected human hippocampal slices, a loss of interneurons and a compensatory upregulation of GABAA receptor binding activity on interneurons, but not PNs, has suggested that disinhibitory GAB...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2015.01.014

    authors: Benes FM

    更新日期:2015-09-01 00:00:00

  • A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain.

    abstract::Using a two-dimensional cell counting approach, a 1991 study in the anterior cingulate cortex (ACCx) detected a reduction in the density of nonpyramidal neurons in layers II-VI of schizophrenic subjects. Schizophrenics without superimposed mood disturbances showed a 16% decrease in layer II, while schizoaffectives sho...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.schres.2004.08.018

    authors: Todtenkopf MS,Vincent SL,Benes FM

    更新日期:2005-02-01 00:00:00

  • Reproducibility of fMRI activations during a story listening task in patients with schizophrenia.

    abstract::A prerequisite to longitudinal fMRI studies in schizophrenia is the knowledge on fMRI signal reliability in schizophrenia patients. We assessed the reproducibility of activations elicited by two fMRI sessions, which were 21 months apart, of a story listening paradigm in 10 schizophrenia patients and 10 healthy subject...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.01.025

    authors: Maïza O,Mazoyer B,Hervé PY,Razafimandimby A,Dollfus S,Tzourio-Mazoyer N

    更新日期:2011-05-01 00:00:00

  • Schizophrenia and HLA: a review.

    abstract::A number of reports of genetic association of human leucocyte antigens (HLA) and alleles with schizophrenia have recently been published. A schizophrenia locus on chromosome 6p near the HLA region has also been reported, on the basis of linkage studies. We have therefore reviewed the investigations of association of H...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(00)00022-0

    authors: Wright P,Nimgaonkar VL,Donaldson PT,Murray RM

    更新日期:2001-01-15 00:00:00

  • The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions.

    abstract:OBJECTIVE:The aim of this study was to test the goodness-of-fit of all previously published five-factor models of the Positive and Negative Syndrome Scale (PANSS). METHODS:We used confirmatory factor analysis (CFA) with a large data set (N = 5769). RESULTS:The different subsamples were tested for heterogeneity and we...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.04.001

    authors: van der Gaag M,Cuijpers A,Hoffman T,Remijsen M,Hijman R,de Haan L,van Meijel B,van Harten PN,Valmaggia L,de Hert M,Wiersma D

    更新日期:2006-07-01 00:00:00

  • Changes in brain gene expression in schizophrenic and depressed patients.

    abstract::Poly(A+) mRNA was extracted from the post-mortem brain of schizophrenics (9 subjects), unipolar depressives (5 subjects) and controls (10 subjects) and used to direct the in vitro translation of radiolabelled protein in a cell-free reticulocyte-lysate system. Protein species were analysed on two-dimensional gels. Over...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(92)90002-m

    authors: Perrett CW,Whatley SA,Ferrier IN,Marchbanks RM

    更新日期:1992-03-01 00:00:00

  • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

    abstract:UNLABELLED:One important risk factor for cardiovascular disease is the metabolic syndrome (MS), yet limited data exist on its prevalence in US patients with schizophrenia. METHODS:Using baseline data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial, assessment of MS prev...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.07.014

    authors: McEvoy JP,Meyer JM,Goff DC,Nasrallah HA,Davis SM,Sullivan L,Meltzer HY,Hsiao J,Scott Stroup T,Lieberman JA

    更新日期:2005-12-01 00:00:00

  • Adjunctive psychosocial therapies for the treatment of schizophrenia.

    abstract::Antipsychotic pharmacotherapy is the standard of care for the treatment of schizophrenia. Although pharmacotherapy effectively improves some symptoms, others can remain. Pharmacotherapy alone also tends to produce only limited improvement in social functioning and quality of life. Supportive psychosocial therapies hav...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2007.12.468

    authors: Patterson TL,Leeuwenkamp OR

    更新日期:2008-03-01 00:00:00

  • Differences in cerebellar blood volume in schizophrenia and bipolar disorder.

    abstract::Brain morphometry has been studied extensively in schizophrenic patients, and among the cortical differences identified two consistent findings are decreased cerebellar vermal volume and increased volume of the fourth ventricle; although contradictory findings are reported as well. Recent cognitive activation studies ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00137-6

    authors: Loeber RT,Sherwood AR,Renshaw PF,Cohen BM,Yurgelun-Todd DA

    更新日期:1999-05-04 00:00:00

  • An assessment of the Wisconsin Card Sorting Test as an indicator of liability to schizophrenia.

    abstract::In order to test the hypothesis that a poor performance in the Wisconsin test (WCST) may be an indicator of liability to schizophrenia, we compared the WCST performances of patients with DSM III-R schizophrenia, normal controls, and patients with schizotypal personality disorder (SZT PD). While schizophrenic patients ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)90007-8

    authors: Battaglia M,Abbruzzese M,Ferri S,Scarone S,Bellodi L,Smeraldi E

    更新日期:1994-12-01 00:00:00

  • Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?

    abstract::Individuals diagnosed with schizophrenia spectrum disorders have significant neuropsychological deficits that have been linked to poor functional outcome. As more treatments are developed and implemented for cognitive impairments, it will be important to consider whether people with schizophrenia have insight into the...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.07.007

    authors: Medalia A,Thysen J,Freilich B

    更新日期:2008-10-01 00:00:00

  • Schizophrenic births and viral diseases in two states.

    abstract::In order to investigate a possible relationship between schizophrenic births and viral diseases, the birth month and year of all state hospital admissions for schizophrenia in Connecticut and Massachusetts from 1973-1974 were compared with the occurrence of reportable viral diseases for 1920-1955. Data was statistical...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(88)90043-6

    authors: Torrey EF,Rawlings R,Waldman IN

    更新日期:1988-01-01 00:00:00

  • A novel approach to measuring response and remission in schizophrenia in clinical trials.

    abstract:BACKGROUND:Pharmaceutical companies conduct clinical trials to show the efficacy and safety of new medications for the treatment of schizophrenia. After the new medications are marketed, clinicians treating patients with schizophrenia discover that a considerable number of patients do not respond to these new medicatio...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2017.03.020

    authors: Aboraya A,Leucht S,Nasrallah HA,Samara M,Haro JM,Elshazly A,Zangeneh M

    更新日期:2017-12-01 00:00:00

  • Subjective and objective quality of life in schizophrenia.

    abstract:OBJECTIVE:Quality of life (QOL) is considered an important outcome in the treatment of schizophrenia, but the determinants of QOL are poorly understood in this population. Furthermore, previous studies have relied on combined measures of subjective QOL (usually defined as life satisfaction) and objective QOL (usually d...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.09.001

    authors: Narvaez JM,Twamley EW,McKibbin CL,Heaton RK,Patterson TL

    更新日期:2008-01-01 00:00:00

  • Grey matter networks in people at increased familial risk for schizophrenia.

    abstract::Grey matter brain networks are disrupted in schizophrenia, but it is still unclear at which point during the development of the illness these disruptions arise and whether these can be associated with behavioural predictors of schizophrenia. We investigated if single-subject grey matter networks were disrupted in a sa...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.08.025

    authors: Tijms BM,Sprooten E,Job D,Johnstone EC,Owens DG,Willshaw D,Seriès P,Lawrie SM

    更新日期:2015-10-01 00:00:00

  • Language-related gamma EEG frontal reduction is associated with positive symptoms in schizophrenia patients.

    abstract:OBJECTIVES:Frontal hypoactivation has been consistently found in schizophrenia. We hypothesized that patients' deficit is asymmetrical, i.e., centred over the left frontal locations, associated with loss of language-related asymmetry, and correlated with positive symptoms. METHOD:The amplitude of EEG gamma band (36-48...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.04.003

    authors: Spironelli C,Angrilli A

    更新日期:2015-06-01 00:00:00

  • Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.

    abstract:BACKGROUND:There is increased interest in the impact of new long-acting treatments on health-related quality of life (HRQoL) in patients with schizophrenia. The aim of this study was to evaluate the impact of treatment with subcutaneous injections of RBP-7000, a new sustained-release formulation of risperidone, compare...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.schres.2016.03.020

    authors: Isitt JJ,Nadipelli VR,Kouassi A,Fava M,Heidbreder C

    更新日期:2016-07-01 00:00:00